RESUMO
BACKGROUND AND OBJECTIVE: Mutations in isocitrate dehydrogenase 1 (IDH1) play a crucial role in the prognosis, diagnosis, and treatment of gliomas. However, current methods for determining its mutation status, such as immunohistochemistry and gene sequencing, are difficult to implement widely in routine clinical diagnosis. Recent studies have shown that using deep learning methods based on pathological images of glioma can predict the mutation status of the IDH1 gene. However, our research focuses on utilizing multi-scale information in pathological images to improve the accuracy of predicting IDH1 gene mutations, thereby providing an accurate and cost-effective prediction method for routine clinical diagnosis. METHODS: In this paper, we propose a multi-scale fusion gene identification network (MultiGeneNet). The network first uses two feature extractors to obtain feature maps at different scale images, and then by employing a bilinear pooling layer based on Hadamard product to realize the fusion of multi-scale features. Through fully exploiting the complementarity among features at different scales, we are able to obtain a more comprehensive and rich representation of multi-scale features. RESULTS: Based on the Hematoxylin and Eosin stained pathological section dataset of 296 patients, our method achieved an accuracy of 83.575 % and an AUC of 0.886, thus significantly outperforming other single-scale methods. CONCLUSIONS: Our method can be deployed in medical aid systems at very low cost, serving as a diagnostic or prognostic tool for glioma patients in medically underserved areas.
